Invasive zygomycosis: update onpathogenesis, clinical manifestations, and management

Author(s): Kontoyiannis D, Lewis R


Zygomycosis is an increasingly common infection in immunocompromised patients. Advances in the understanding of Zygomycetes pathobiology and the introduction of new drugs with improved activity and tolerability for treatment of zygomycosis have improved the prospects of effectively controlling this devastating infection. Further reductions in mortality will require improved diagnostic and novel therapeutic approaches for this group of aggressive opportunistic molds.

Similar Articles

Nosocomial infection with Rhizopus microspores in preterm infants: association with wooden tongue depressors

Author(s): Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM, et al.

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

Author(s): Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA,et al.

Mucormycosis in children: a study of 22 cases in a Mexican hospital

Author(s): Bonifaz A, Tirado-Sanchez A, Calderon L, Romero-Cabello R, Kassack J,et al.

Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)

Author(s): Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP, et al.

Outbreak of Cutaneous Rhizopus arrhizus Infection Associated with Karaya Ostomy Bags

Author(s): Mysheika, Williams L, Lauren A,Burwell, Salisbury D , et al.